Corbus Pharmaceuticals Newsroom

Corbus Pharmaceuticals Holdings Inc. Stock Rises Tuesday, Still Underperforms Market

MarketWatchDec 24 17:30 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Corbus Pharmaceuticals (CRBP) and Fortrea Holdings Inc. (FTRE)

TipRanksDec 17 05:30 ET · Ratings

Mizuho Securities Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating

Moomoo NewsDec 16 13:32 ET · Ratings

Promising Potential of Corbus Pharmaceuticals: Buy Rating Reinforced by Key Assets and Strategic Focus

TipRanksDec 12 02:15 ET · Ratings

Express News | Corbus Pharmaceuticals Announces Dosing of First Patient in Its First-in-Human Study of Crb-601 to Treat Patients With Advanced Solid Tumors

ReutersDec 9 07:00 ET

Corbus Pharmaceuticals Announces Dosing of First Patient in Its First-In-Human Study of CRB-601 to Treat Patients With Advanced Solid Tumors

Corbus PharmaceuticalsDec 9 00:00 ET

Corbus Pharmaceuticals Receives Fast Track From FDA for Cervical Cancer Treatment

WSJDec 3 07:20 ET

Corbus Pharmaceuticals Announces U.S. FDA Granted FTD to CRB-701

TipRanksDec 3 07:06 ET

Express News | Corbus Pharmaceuticals Holdings Inc - First Data From Dose Escalation Study Expected in Q1 2025

ReutersDec 3 07:04 ET

Express News | FDA Grants Fast Track Designation to Crb-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

ReutersDec 3 07:00 ET

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

Corbus PharmaceuticalsDec 3 00:00 ET

Corbus Pharmaceuticals Price Target Announced at $35.00/Share by Piper Sandler

Dow JonesDec 2 05:57 ET · Ratings

Corbus Pharmaceuticals Analyst Ratings

BenzingaDec 2 05:46 ET · Ratings

Piper Sandler Initiates Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Announces Target Price $35

Moomoo NewsDec 2 05:34 ET · Ratings

Express News | Corbus Pharmaceuticals Holdings Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $35

ReutersDec 2 04:15 ET

Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now

Yahoo FinanceNov 26 06:54 ET

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference

GlobeNewswireNov 21 08:00 ET

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GlobeNewswireNov 12 08:00 ET

We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate

Yahoo FinanceNov 9 09:39 ET

RBC Capital Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $65

Moomoo NewsNov 8 21:32 ET · Ratings